149 related articles for article (PubMed ID: 16931136)
1. Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle.
Jiang JH; Wang N; Li A; Liao WT; Pan ZG; Mai SJ; Li DJ; Zeng MS; Wen JM; Zeng YX
J Clin Virol; 2006 Oct; 37(2):98-103. PubMed ID: 16931136
[TBL] [Abstract][Full Text] [Related]
2. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
3. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
5. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
Chang Y; Lee HH; Chen YT; Lu J; Wu SY; Chen CW; Takada K; Tsai CH
J Virol; 2006 Aug; 80(15):7748-55. PubMed ID: 16840354
[TBL] [Abstract][Full Text] [Related]
6. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
9. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
10. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr Virus infected B cells.
Konforte D; Paige CJ
Virus Res; 2009 Sep; 144(1-2):339-43. PubMed ID: 19447148
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
[TBL] [Abstract][Full Text] [Related]
13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation cycle changes of Epstein-Barr virus in nasopharyngeal carcinoma cell line CNE after infection].
He YW; Zeng J; Ou XL; Zhang G; Du J
Ai Zheng; 2008 May; 27(5):455-9. PubMed ID: 18479592
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
[TBL] [Abstract][Full Text] [Related]
17. Lytic cycle gene regulation of Epstein-Barr virus.
Amon W; Binné UK; Bryant H; Jenkins PJ; Karstegl CE; Farrell PJ
J Virol; 2004 Dec; 78(24):13460-9. PubMed ID: 15564457
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents.
Rodriguez A; Jung EJ; Flemington EK
J Virol; 2001 May; 75(10):4482-9. PubMed ID: 11312318
[TBL] [Abstract][Full Text] [Related]
19. The activation of lytic replication of Epstein-Barr virus by baculovirus-mediated gene transduction.
Wang L; Shan L; Yin J; Zhao M; Su D; Zhong J
Arch Virol; 2006 Oct; 151(10):2047-53. PubMed ID: 16673043
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
